CXCL10 and COVID-19: This is consistent with other COVID-19 studies associating severe disease with impaired epithelial interferon responses, fewer local IFN-α-producing plasmacytoid dendritic cells, and mucosal IP-10 levels that correlated with interferon responses (28, –, 30).